Xolair 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCZF2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,901
Award facts
- Contract value 100% obligated
- $37,901.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37,901.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The contract, issued on January 12, 2026, with an ultimate completion date of February 3, 2026, carries no set-aside designation, indicating the awardee competed in unrestricted federal procurement. DMS Pharmaceutical Group was selected as the sole awardee, with no subcontractor involvement identified in the award documentation.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a comprehensive $30.3 billion acquisition strategy that established multiple regional prime vendor contractors to supply the Department of Defense with diverse pharmaceutical products and medical consumables. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, vaccines, and related medical supplies to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for federal military medical operations.
Quick answers
Who was awarded contract SPE2DR26FCZF2?
SPE2DR26FCZF2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FCZF2 worth?
The government has obligated $37,901 on SPE2DR26FCZF2.
Is contract SPE2DR26FCZF2 an order under another contract?
Yes. SPE2DR26FCZF2 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZF2 competed?
The extent of competition for SPE2DR26FCZF2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award